Disobeying disclaimer directives

• 29 March 2023 09:27 UTC+02:00
• [ perma(?)link ]
• < previous | next >

I've received one identical message from Anna prior to this, and didn't give it much thought. It's not the usual predatory shitnitz; it's neither incompetent—other than being completely irrelevant to me—nor offensive…nor particularly interesting. And she's not egregiously lying to me, unlike that spambitch Gillian Francis. So Anna has not incurred my wrath, and is not deserving of my puerile telling-her-she's-a-ho-without-saying-she's-a-ho shtick.

Nevertheless, there's that boilerplate disclaimer to an unsolicited email. This message was sent directly to me, and I was named. Therefore I am the intended recipient, I haven't received it by mistake. But if the information is intended only for me, I shouldn't divulge it to anyone else. Actually, it contains nothing of commercial, or any, interest; so I don't understand why it should be kept to myself.

Yes, I know, boilerplate; it'll be attached automatically to all outgoing messages. And it's not really outrageous. It's just the presumptuousness of a spammer dictating their requirements to a UCE recipient that irritates me.

So I'm going to not comply, by posting it here. What a little shit I am.

Sender: anna.schmidt-lefevre@mg.rdinnomatching.com
Date: Tue, 28 Mar 2023 22:46:28 +0000
Subject: Collaboration proposals with top chemical and pharma companies on small molecules
From: Anna Schmidt <anna.schmidt-lefevre@mg.rdinnomatching.com>

I am reaching out to you as we have been tasked by more than 50 large and medium chemical and pharma companies to look for compounds from academia, start-ups, and SMEs. These companies offer different partnering programs where they will screen these compounds to find new applications: it could be in various therapeutic areas but also other research areas such as crop sciences, animal health, cosmetics, food, etc. Each company has specific criteria for its screening and offers different benefits such as grants, patents, and publications. Would you be interested in a short introductory phone call in the next few days with the manager of these partnering programs to give you more details and answer questions you may have? For your information, Inospin has a network of 500+ innovation-driven leading companies with active external R&D programs, which are available on dedicated partnering platforms where academics and innovative SMEs can submit their proposals for collaboration. Thank you, Kind regards, Anna Schmidt | Project Coordinator Academia-Industry Collaboration Unit anna.schmidt-lefevre@rdinospin.com Inospin SA | http://www.inospin.com Disclaimer: The information contained in this e-mail is intended only for the individual addressed. If you have received this e-mail by mistake, please notify us immediately by return reply. Be sure to delete this message and all its attachments from your system. Please note that any unauthorized review, copying, disclosure or any other use of this information is strictly prohibited. E-mail transmission cannot be guaranteed to be secure or error-free as information could be intercepted, corrupted, lost, destroyed, received late or incomplete, or could contain viruses. The sender therefore does not accept any liability for any error or omission in the content of this message, either of which are caused as a result of e-mail transmission. If verification is required, please request a hard-copy version. Thank you. If you don’t want to receive emails from us, please click here.

Sender: laura.alonso@mg.rdinnomatching.com
Date: Fri, 11 Oct 2024 06:59:19 +0000
Subject: [snip], Your methods in the publication "[snip]" are missing
From: Laura Alonso <laura.alonso@mg.rdinnomatching.com>

Date: Fri, 11 Oct 2024 10:27:01 +0100
Subject: Re: [snip], Your methods in the publication "[snip]" are missing
To: Laura Alonso <laura.alonso@rdinospin.com>